It proposes two proactive measures: screening for the G6PD rs72554664 mutation in those with G6PD deficiency to evaluate their T2DM risk, and regular glucose monitoring for hemizygous males with the G6PD rs72554664-T risk allele. Here, G6PD is linked to G6PD deficiency.